GlyTherix Ltd signs Lutetium-177 supply agreement with ANSTO

GlyTherix Ltd signs Lutetium-177 supply agreement with ANSTO

ANSTO to supply Lutetium-177 for GlyTherix’s Phase Ib therapeutic trial in patients with prostate, pancreatic and bladder cancers Phase Ib basket clinical trial expected to start in late 2023 Sydney, Australia – February 21, 2023 – GlyTherix Ltd, an Australian...